chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On March 25th was a red raised rash at injection, warm to the touch and very sensitive. On the 27th I developed a bruise and the mark turned into a circle and spread down my arm 3 inches across. By the 29th of March it turned into a defined irregular square about 6 1/2 inches across and 4 inches tall and it stayed like that for over a month. I did a remote doctors appointment on March 27th and I was prescribed Motrin and antibiotics for a week. In about three months the rash went away completely and I was back to normal.
Signs/Symptoms: Pt complained of breathing difficulty, denied chest pain, no N/V. Initially lungs were clear, heart regular, 80 pulse, BP 148/89, O2 sat 98%.  Plan: client removed to clinical area, who then had audible wheezing, tachycardic, no swelling tongue/lips, remained alert, oriented. Clinic director contacted, requested client to be given Epinephrine 0.3mg administered, albuterol nebulizer started, fire rescued summoned, and client transported alert to health center. Husband in clinic accompanied her.
Red rash in a big patch over where I got the shot. Itches and a little sore. Hot to the touch. 7 days after shot.
This spontaneous report as received from a pharmacist via a representative refers to a female patient of unknown age. On an unspecified date, the patient was vaccinated with a dose of PNEUMOVAX 23 (dose, lot# and route not reported) as directed in a arm. Concomitant therapies included influenza virus vaccine (manufacturer unknown) in the opposite arm. "Over 1 year ago", the patients whole arm turned red after administration with PNEUMOVAX 23. The patient sought medication attention via office visit with the primary care physician. PNEUMOVAX 23 was not reintroduced. The patient had no respiratory issues reported. The outcome of the event was unknown. Additional information has been requested.
Information has been received from a consumer for the Pregnancy Registry for GARDASIL concerning her daughter a 14 year old female with no known medical history reported, who on 14-APR-2008 was vaccinated intramuscularly with a 0.5 mL first dose of GARDASIL (Lot # unknown). On the same day the patient was also vaccinated with a dose of VARIVAX (Lot # unknown) and VAQTA. The caller stated that her daughter received the three vaccines and discovered she was pregnant. At the time of the report the patient was 7 weeks gestation (LMP 12-MAR-2008). No AE reported. The patient had bloodwork and a pelvic exam performed. Outcome unknown. No product quality complaint was involved. Follow up information has been received from a physician, who reported that the 14 year old patient had a termination of her pregnancy soon after her pregnancy diagnosis (date not provided). The termination was not related to having had the GARDASIL vaccine. Upon internal review, termination of pregnancy was considered an other important medical event. No further information is available.
At 1220 on 3/29/07 mother called her daughter c/o pain and being sick. Mom states low grade fever is giving her Tylenol, lump at varicella site, also states has to come back in 6 mo. I ask her to measure site said it sound like a normal type reaction. Upon return to office child does not need shots in 6 months.
Within minutes of my first pfizer-biontech covid-19 vaccine eua, my arm began to swell and was very painful to touch and movement that lasted for two days. Within an hour I felt dizzy, with blurred vision. That only lasted for few hours. Two days after my Second pfizer-biontech covid-19 vaccine eua, I started to experience extreme fatigue around 1pm. The fatigue continued for a total of three days.  On the third day after my second pfizer-biontech covid-19 vaccine eua, I had severe headache across the front, sides and back of my head. As well as feeling Nauseated. The headache and Nausea lasted for 2 days.
This spontaneous report was received from a physician refers to a 28 year old female patient. The patient had no known allergies. On an unknown date in 2008, the patient was vaccinated with a dose of GARDASIL series, (lot number, expiry date and route was not reported). On 17-DEC-2012, the patient had HPV DNA test done and the results of the tests was abnormal. It was positive ASCUS, undetermined significance. The physician stated that the patient was at high risk for cervical cancer. The patient was feeling some fatigue and having some migraines too. The patient would follow up for colposcopy. The patient had not recovered from the events. The patient sought medical attention. Additional information has been requested.
Anigina  Narrative:  Patient received Covid 19 vaccination at 1513. Due to an allergy to honey bees, she was monitored by RN for 30 minutes, ended 1543. When observation period was completed, RN asked patient if she was okay. Employee stated, "I'm having some tightness in my chest, but I'm okay." Employee also stated that she sometimes has SOB and tightness of chest. Vital signs obtained BP 185/82-P 77- R 20- O2 sat 100% room air, T 97.4. BP rechecked 206 /85. Employee asked by staff if she has hypertension, stated yes. Asked by this writer when was the last time she had taken BP medications and she stated today before lunch. Advise that EMS will be notified that she could go to hospital, employee refused. Leadership notified of situation and advised that nursing staff still call 9-1-1. 1554 9-1-1 notified via telephone by RN. Employee asked if any history of heart attack, denied however did disclose history of four heart stents. Approximately 1606 EMS arrived to building 6 to escort employee to hospital, patient refused to go to hospital. Leadership at vaccination clinic, advised employee call 9-1-1 or go to nearest hospital if tightness in chest persist, expressed understanding.
NauseaVomiting flushing Narrative:  Recipient experienced nausea and flushing s/p vaccination, which lasted about 15 minutes prior to spontaneously resolving. No other issues include no vomiting, shortness of breath, dizziness or diarrhea. No reported prior reactions to vaccinations. States she was feeling anxious about vaccination and had eaten prior to coming to clinic. Vital signs T98.2F, BP 104/70 (stated normal range for recipient), HR51 (stated normal range for recipient), SpO2 99% on RA. Exam benign, able to tolerate oral intake of fluids (declined offer of food) and ambulate prior to leaving vaccination area. Observed another ~8 minutes prior to request to go home.
Information has been received from a physician concerning a 20 year old female (D.M.) who on 26-OCT-2007 was vaccinated with the second dose of Gardasil (lot number not reported). On 26-OCT-2007 the patient experienced injection site pain which has persisted to today. No further information is available.
Pt recvd vax on 30JUL92 & approx 10 days following 2nd vax pt devel pruritic hives all over body involving scalp, arms, hands, & feet; also c/o hands & feet felt as though they were on fire;
12 HOURS IN, woke to extreme pain when tried to roll onto effected arm.  24 hours in, pain gets worse, small red patch appears. 30 hours in, large red patch, 2-3" in diameter. Hot to touch, painful even to touch the skin lightly. Not just soreness, feels more like a bone bruise. Can't touch it, put pressure on it. Some difficulty moving arm, say to dress. 40 hours in, went to walk-in clinic to make sure there wasn't infection at injection site or cellulitis. None present, but told it was a fairly extreme local reaction.  Am now applying steriod cream to area, and told to keep an eye on it to make sure it doens't turn into cellulitis, etc.
really sick, pretty sick; had severe aches, pains; fever; Cold chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (really sick, pretty sick), PAIN (had severe aches, pains), PYREXIA (fever) and CHILLS (Cold chills) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (really sick, pretty sick), PAIN (had severe aches, pains), PYREXIA (fever) and CHILLS (Cold chills). At the time of the report, ILLNESS (really sick, pretty sick), PAIN (had severe aches, pains), PYREXIA (fever) and CHILLS (Cold chills) had resolved.            No concomitant and treatment information were reported by the reporter
This spontaneous report as received from a certified medical assistant refers to multiple patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant medications were not reported. In August 2016, reported as dates starting on or after 04-AUG-2016, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB lot # M010212, expiry date 02-JAN-2019 (strength, dose, route and site of administration were not reported). No adverse effect was reported. Administered doses of vaccines experienced the temperature excursion of 35 degrees Fahrenheit for 6 hours and 25 minutes and 47 degrees Fahrenheit for 15 minutes. Data logger was involved. There were no previous temperature excursions reported. This is one of several cases received from the same reporter. Additional information has been requested.
Pt reports to nurse at a 4-17-12 clinic visit, after she received the Hepatitis B vaccine on 3-20-12, two day after the vaccine she had to go to ER because of breathing difficulties." Was told by ER doctor she had an allergic reaction." Pt thinks is was an allergic reaction to the Hepatitis B vaccine.
Painful, can't raise right arm above shoulder level. Swollen around site of injection. Given 60mg Toradol FM, Naprosyn 500mg and Vicodin.
R upper arm indurated, red, soreness and itchy. By the time he was evaluated at clinic redness had recovered. Area of redness 6cm by 7cm, 2cm induration. Gave Ibuprofen suspension and Benadryl elixir.
t103, screaming, crying & irritable; mom reported occurred in PM of inject; exam revealed local rxn including red, swollen, hot & tender;
itching,  slight heaviness in chest with cough, very tired went to sleep as so as I arrived home after the shot, red welt on arm around area of injection when awoke in morning.
Migraine; uncontrollable Tremors (night and day); difficulty of breathing; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine), TREMOR (uncontrollable Tremors (night and day)) and DYSPNOEA (difficulty of breathing) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Fibromyalgia, Asthma, Dystonia, Food allergy (Allergic to  mint of all varieties) and Drug allergy (codeine). Concomitant products included TIZANIDINE HYDROCHLORIDE (ZANAFLEX) and TERBUTALINE for an unknown indication.   On 26-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, the patient experienced MIGRAINE (Migraine), TREMOR (uncontrollable Tremors (night and day)) and DYSPNOEA (difficulty of breathing). At the time of the report, MIGRAINE (Migraine), TREMOR (uncontrollable Tremors (night and day)) and DYSPNOEA (difficulty of breathing) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound scan: normal (normal) Normal.         No treatment medication was reported  It was reported that patient till now experience tremors (night and day), migraine and difficulty of breathing.   The patient underwent laboratory test  X-RAY showed no result.
Pt was given a 2nd Pfizer vaccine 11 days after receiving the first vaccine (received vaccine on 4-30-2021 after receiving vaccination on 4-19-2021)
pale, diaphoretic, lungs clear, no pain, felt better after given juice (had not eaten prior to vaccine)  arrived-EKG showed ST elevation Administered aspirin
Patient received a dose of proquad following temperature excursion; no adverse effect; This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender.     The patient's medical history, concurrent conditions and concomitant medications were unknown. On 13-NOV-2019, the patient received a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (therapy type: data logger) (lot # S017240 exp.date: 01-DEC-2020) (strength, dose, frequency, lot/batch number and anatomical location was unknown) for prophylaxis following a temperature excursion (product storage error).        No adverse events were reported. It was reported that the vaccine was stored at a temperature of 47 degree Fahrenheit to 77 degree Fahrenheit (9 degree Celsius to 25 degree Celsius) (47 Fahrenheit) for a time frame of 47 hours. There is no previous temperature excursion. No product quality compliant was reported.  The outcome of product storage error and no adverse event was unknown.
Vertigo off and on yesterday.  Loud tinnitus in left ear last night for 3 hours until subsiding.  Woke me from sleep.
Patient sat for about 5 minutes after dose then reported not feeling well. She stated she was extremely hot then fainted. She was conscious but stayed out for about 3 minutes before fully coming to.
Persistant fever 100-103 Chills Headache Nausea Body Ache Loss of Appetite Aversion to Light Difficulty taking liquids Very tight stomach Extreme fatigue
pt looked funny & had an irregular breathing pattern, brought pt to MD;  noted to be pale w/irregular resp; flush BP 106, t100.4; no sz activity noted; mom instructed to watch pt @ home;
Patient w/ history of anxiety and bipolar, felt warm and anxious immediately after vaccine. BP initially 170/100 HR98, decreased to 152/105, HR 86.
pt recvd vax & 3 days post vax exp diarrhea,nausea,vomiting,high fever;sx persisted for 48hrs & then abated;
loss of vision; leg felt funny; felt off-balance/ loss of equilibrium; eyes pinpoint; left leg asleep, couldn't move leg; slurred speech; dizzy; golf ball to softball sized pressure on lower back/kidney area; couldn't straighten back; cardiovascular incident; This is a spontaneous report received from contactable reporter (Consumer or other non HCP). The reporter is the patient.  2022NVX-US-000002730   A female patient received BNT162b2 (BNT162B2), on 15Apr2021 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BLINDNESS (medically significant), outcome "unknown", described as "loss of vision"; LIMB DISCOMFORT (non-serious), outcome "unknown", described as "leg felt funny"; BALANCE DISORDER (non-serious), outcome "unknown", described as "felt off-balance/ loss of equilibrium"; MIOSIS (non-serious), outcome "unknown", described as "eyes pinpoint"; MOVEMENT DISORDER (non-serious), outcome "unknown", described as "left leg asleep, couldn't move leg"; DYSARTHRIA (non-serious), outcome "unknown", described as "slurred speech"; DIZZINESS (non-serious), outcome "unknown", described as "dizzy"; MUSCULOSKELETAL DISCOMFORT (non-serious), outcome "unknown", described as "golf ball to softball sized pressure on lower back/kidney area"; BACK DISORDER (non-serious), outcome "unknown", described as "couldn't straighten back"; CARDIOVASCULAR DISORDER (non-serious), outcome "unknown", described as "cardiovascular incident". The patient experienced symptoms of loss of vision, leg felt funny, felt off-balance, eyes pinpoint, left leg asleep, couldn't move leg, slurred speech, dizzy, loss of equilibrium, golf ball to softball sized pressure on lower back/kidney area, couldn't straighten back, was suddenly craving meat after being vegetarian, and a cardiovascular incident.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Pt was at work, laying tile, and developed sudden onset of chest, back, neck and left arm pain, with associated dizziness around 10:15AM 5/10/21. He sat down for bit and symptoms persisted.  He vomited x1 and went home, assuming he had developed the same "24 GI bug" his daughter had over the weekend. Once home he continued to feel unwell.  He called his mother who proceeded to call EMS.  EKG revealed anterior and inferior STE and he was taken directly to cardio lab for emergent coronary angiography, where he was found to have total thrombotic occlusion of midLAD, treated with drug-eluting stents.
Patient states she immediately had severe pain after the vaccine leading to loss of work the following day.  Says pain was severe for about 3 days but has continued now for 15 days.  States now it only causes pain when moving in certain ways but pain is reported at a 6 currently when occurs.  She has been using acetaminophen and Ibuprofen to treat.
This is a spontaneous report from a contactable consumer (patient's parent). This report was received via a Pfizer sales representative. An 18-year-old female patient received the first dose of TRUMENBA (batch number and expiration date were not reported), intramuscular in the upper arm on an unspecified date (reported as two years ago approximately) at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The reporter was a medical assistant and it was the patient whom she administered the vaccine to and the patient ended up with big red mark that was very swollen after the first dose and it did disappear within a couple of weeks. No follow-up attempts are possible, information about batch number cannot be obtained.
Patient is here today for her second Pfizer vaccination.  She reports that after the first vaccine, she felt very cold and had a sore arm for about 4 days.  States that she took a 3-4 hour nap after she got home and the chills improved/resolved.  Reports that she received the vaccine at around 10:00 AM.  Was in the waiting area and was having some blurring of vision that was "coming in and out" and dizziness.   She was taken to the personal observation area to lie down at 10:36 AM.  Vital signs monitored.  Blood pressure elevated, even though symptoms of blurring vision resolved.   At around 10:55 AM, patient sat up on edge of cot.  Continues to reports symptoms have resolved.  No return of symptoms with standing.  Patient walked well without the need of assistance.  Husband accompanied her out of facility.    Advised that, should blurring of vision reoccur, she should be seen in ED.  Advised to schedule a blood pressure recheck with her PCP before the weekend.  Patient acknowledged understanding of above information.
Headache and body aches. Afebrile. Nausea. Low back pain.
Information has been received from a physician referring to a 14 year old male patient. Information about the patient's concurrent condition, concomitant medication and medical history was not provided. On an unknown date, the patient was vaccinated with improperly stored (Temperature: 47 Fahrenheit to 77 Fahrenheit; Time frame: 40 minutes) doses of GARDASIL 9 (lot # M043731, expiration date: 22-JUN-2019; the dose and route were not reported) for prophylaxis on an unspecified date after July 2017. No adverse effect reported. It was reported that there were no previous temperature excursions and there was a data logger involved. This is one of the multiple reports received from the same reporter. Sender's Comments: US-009507513-1707USA006271.
I woke up in the morning with a tiny bruise under neat my left eye. I do have a photo. It disappeared the day after.
This spontaneous report as received from a healthcare worker refers to a unspecified number of patient of unknown age and gender. On an unknown date, the patients were vaccinated with RECOMBIVAX HB (dose, route and Lot# not reported under which supported temperature excursions. No adverse experiences were reported. This is one of several reports from the same source. Additional information has been requested.
Experienced little arm hurt; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Experienced little arm hurt) and NAUSEA (Nausea) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-May-2021, the patient experienced MYALGIA (Experienced little arm hurt) and NAUSEA (Nausea). At the time of the report, MYALGIA (Experienced little arm hurt) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported. No Treatment information was reported.
(L) upper extremity tender to touch, mild erythema to area. Slightly warm to touch, pain and soreness in area. Pt. has numbness and tingling in area as well. Instructed to apply cold compresses and take OTC NSAIDS. Will call in 2 days for a follow up.
Sick from first dose; This case was reported by a consumer via (Chatbot) interactive digital media and described the occurrence of sickness in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   It was unknown if the reporter considered the sickness to be related to Shingrix.  Additional details was reported as follows: The case was reported by patient. The age at vaccination was not reported. The age group was not reported but was captured adult as per vaccine indication. The patient was sick after vaccination. No other information was available.
5 inch red circle/bump on right shoulder (shoulder of injection).  Circle is bright red and itchy.  Tender to touch.  Appeared the morning after second vaccination.  This did not occur after first vaccination shot.  Online it's refered to as "covid arm".
Fever; target-lesions (erythema multiforme); decreased appetite w/in 24 hours of administration of vaccines.
Nondescript mild dizziness about 10 minutes after his shot. No other symptoms such as warmth, diaphoresis, nausea, or visual changes. Symptom resolved spontaneously.  No orthostasis on vitals. VSS throughout short stay in Observation.   Initial BP 134/80, Pulse 77, O2 sat 97%.
sore arm after the injection for several hours. by 11 pm on day of injection i had a fever of 101 until 3/7/2021. Cold sweats, chills, headache for four days, swollen lymph nodes under arms until 3/10/21, body aches until fever subsides.
The first dose only gave me a slight headache and minor body aches that lasted about 2 weeks. I didn't miss any work and I didn't have any trouble with my stamina. After the second dose, I had an extreme migraine-level headache the next day, which resulted in me missing work. I also suffered from an exhausted feeling and my stamina isn't what it was before the second dose. This headache persisted to a lesser extent for the next 2 to 3 weeks. It seems that my allergies and related symptoms have become worse than usual after the second does. I have went to my doctor twice because of severe congestion and sinus headaches. I am still suffering from fatigue and my stamina isn't what it normally is regardless how much rest I am get. I seem to be having slightly more difficulty with my colitis but it isn't a flare-up but more of a discomfort. I wasn't having any of the fatigue or stamina problems before taking the vaccine.